Flecainide Reduces Ventricular Arrhythmias in Patients With Genotype RyR2-positive Catecholaminergic Polymorphic Ventricular Tachycardia. [electronic resource]
Producer: 20180824Description: 185-191 p. digitalISSN:- 1885-5857
- Adult
- Anti-Arrhythmia Agents -- administration & dosage
- DNA Mutational Analysis
- Death, Sudden, Cardiac -- epidemiology
- Electrocardiography
- Female
- Flecainide -- therapeutic use
- Follow-Up Studies
- Genotype
- Humans
- Male
- Mutation
- Ryanodine Receptor Calcium Release Channel -- genetics
- Tachycardia, Ventricular -- genetics
- Polymorphic Catecholaminergic Ventricular Tachycardia
No physical items for this record
Publication Type: Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.